Extavia®
Showing 1 - 25 of >10,000
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Multiple Sclerosis Trial in Berlin, Potsdam (Verum arm receiving Gilenya®, Active Comparator receiving Extavia®)
Terminated
- Multiple Sclerosis
- Verum arm receiving Gilenya®
- Active Comparator receiving Extavia®
-
Berlin, Germany
- +1 more
Jul 28, 2021
Relapsing Multiple Sclerosis Trial (Placebo, BIIB061, Interferon-beta1)
Not yet recruiting
- Relapsing Multiple Sclerosis
- Placebo
- +3 more
- (no location specified)
Mar 22, 2021
Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Early Highly Effective Therapies Group
- Escalation Therapies Group
-
Aurora, Colorado
- +30 more
Jul 22, 2022
Relapsing Remitting Multiple Sclerosis Trial in Portugal (peginterferon beta-1a, interferon beta-1a, interferon beta-1b)
Completed
- Relapsing Remitting Multiple Sclerosis
- peginterferon beta-1a
- +2 more
-
Amadora, Portugal
- +14 more
Nov 23, 2020
Interferon Beta Therapy in Participants With Multiple Sclerosis
Completed
- Multiple Sclerosis, Relapsing-Remitting
- SC Peginterferon beta-1a
- +2 more
-
Göttingen, GermanyResearch Site
Sep 24, 2019
Corona Virus Infection, Sars-CoV2 Trial in France (Vitamins, Telmisartan, Ciclesonide)
Completed
- Corona Virus Infection
- Sars-CoV2
- Vitamins
- +3 more
-
Bordeaux, France
- +6 more
Feb 3, 2022
EPID Multiple Sclerosis Pregnancy Study
Completed
- Multiple Sclerosis
- Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG
- +6 more
-
Multiple Locations, FinlandMany locations
Aug 12, 2019
Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Early Aggressive Therapy or Traditional Therapy
-
Birmingham, Alabama
- +51 more
Jan 23, 2023
Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,
Recruiting
- Atrial Fibrillation
- Heart rhythm measurements with Preventicus®
- +3 more
-
Genk, Limburg, BelgiumZiekenhuis Oost-Limburg
Aug 28, 2023
ECMO Braile Biomédica® in COVID-19 Patients
Recruiting
- COVID-19
- Patients underwent cardiorespiratory support
-
Lago Sul, Brasília - DF, BrazilHospital Brasília
Oct 13, 2023
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)
Recruiting
- Venous Leg Ulcer
- Diabetic Foot
- AQUACEL® Ag+ Extra™
- Cutimed® Sorbact®
-
Barranquilla, Colombia
- +13 more
May 26, 2023
Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)
Recruiting
- Dental Implants
- Dynamic Computer Assisted Surgery
- Freehand
-
L´hospitalet de Llobregat, Catalunya, SpainUniversity of Barcelona
Aug 31, 2023
Tricuspid Regurgitation, Tricuspid Valve Disease Trial in Worldwide (TricValve® Transcatheter Bicaval Valve System, Medical
Not yet recruiting
- Tricuspid Regurgitation
- Tricuspid Valve Disease
- TricValve® Transcatheter Bicaval Valve System
- Medical Therapy Arm
-
Cleveland, Ohio
- +10 more
Nov 14, 2023
Carpal Tunnel Syndrome Trial in Denizli (KForce Sens, Baseline Electrigoniometer)
Completed
- Carpal Tunnel Syndrome
- KForce Sens
- Baseline Electrıgoniometer
-
Denizli, TurkeyPamukkale University
Sep 14, 2023
Vaccine-Preventable Diseases, Typhoid Fever, Cholera Trial in Helsinki (Oral typhoid fever vaccine, Oral cholera vaccine)
Recruiting
- Vaccine-Preventable Diseases
- +2 more
- Oral typhoid fever vaccine
- Oral cholera vaccine
-
Helsinki, FinlandMeilahti Vaccine Research Center, Helsinki University Hospital
Oct 27, 2023
Observatory on Cow's Milk Protein Allergy
Not yet recruiting
- Food Allergy
- Pepticate® Syneo®
-
Paris, FranceHôpital Trousseau - APHP
Oct 10, 2023
Real Life of TLC-NOSF Dressings in Local Treatment of Chronic
Recruiting
- Real Life Study
- +4 more
- TLC-NOSF dressings (D'URGOSTART PLUS® BORDER, URGOSTART PLUS® PAD and URGOSTART INTERFACE®)
-
Paris, FrancePr Agnès HARTEMANN
Nov 13, 2023
Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)
Recruiting
- Healthy Adult Subjects
- TTYP01
- +2 more
-
San Antonio, TexasICON Early Phase Services
Oct 24, 2023
Epidural; Anesthesia, Headache, Analgesia Trial (Labor analgesia)
Not yet recruiting
- Epidural; Anesthesia, Headache
- Analgesia
- Labor analgesia
- (no location specified)
Oct 11, 2023
EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up
Recruiting
- Joint Diseases
- EVOLUTION® Revision Tibial System and EVOLUTION® Stemmed CS Femur with the EVOLUTION® MP CS Tibial Insert
-
Milan, Piazza C. Ferrari 1 20122 Milan, ItalyGaetano Pini Orthopedic Institute
Nov 16, 2023
Kidney Transplant Trial (Myreptic-N Tablet, Mycophenolate mofetil Tablet/Capsule)
Not yet recruiting
- Kidney Transplant
- Myreptic-N Tablet
- Mycophenolate mofetil Tablet/Capsule
- (no location specified)
Sep 13, 2023
VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During
Not yet recruiting
- Influenza Immunization (Healthy Volunteers)
- Quadrivalent Influenza Vaccine
- High-Dose Quadrivalent Influenza Vaccine
- (no location specified)
Sep 22, 2023
Periodontitis Trial (Enamel matrix derivate, Non-surgical periodontal treatment)
Not yet recruiting
- Periodontitis
- Enamel matrix derivate
- Non-surgical periodontal treatment
- (no location specified)
Oct 8, 2023